Medical Technologies

Medical devices, digital health, medical artificial intelligence, surgical robots, and diagnostic technologies.

107 Articles

Biotech Company Funding Remains Stable Despite the AI Investment Boom

Crunchbase data indicates that global biotech company funding is expected to remain within the $36 billion to $40 billion range in 2026, despite artificial intelligence capturing a large share of venture capital. AI drug design and discovery companies stand out among the largest funding rounds, alongside continued public offerings and acquisition deals in the sector.

2026-08-31

Medical Technologies

Boston Scientific Recalls Imager II Catheters After Tip Detachment Risk

Boston Scientific halted the distribution and use of Imager II Angiographic Catheters after discovering that they were manufactured with low levels of tip bonding materials, which could lead to tip deterioration or detachment inside a blood vessel. The company reported two serious injuries linked to the issue as of July 16, while the FDA issued an early alert about it.

2026-08-31

Medical Technologies

Government Report: Cybersecurity, Data Integration, and Skills Shortages Hinder the Digitization of Healthcare in Egypt

A report issued by the Information and Decision Support Center of the Cabinet reviews the growth of the global digital health market and Egypt’s efforts to digitize its healthcare services, including the creation of 4.5 million electronic health records and the issuance of more than 42 million electronic prescriptions. The report warns that accelerating the transformation requires addressing data security, interoperability, and the shortage of specialized expertise.

2026-08-31

Medical Technologies

Abbott Receives CE Approval for New Left Atrial Appendage Closure Device

Abbott has received the European CE mark for the Amulet 360, an upgraded version of its device for closing the left atrial appendage in certain patients with atrial fibrillation in order to reduce the risk of stroke. The company is preparing to expand the device’s use in European countries in the coming weeks, amid direct competition with Boston Scientific’s Watchman device.

2026-08-28

Medical Technologies

Medtronic Recalls Esophageal pH Monitoring Capsules After 184 Serious Injuries Reported

Medtronic recalled a group of Bravo CF capsules used to monitor esophageal acidity after a defect was linked to 184 serious injuries, with no deaths reported through August 10, 2026. The defect may cause the capsule to fail to attach or detach, with risks including airway obstruction, esophageal perforation, and a retained foreign body inside the patient.

2026-08-28

Medical Technologies

AI-Powered Software Addresses the Focusing Problem in Microscope Images

Turkey’s KTÜ İLAFAR center has developed AI-powered software aimed at producing clear microscopic images across a sample while creating three-dimensional models of tissues and cells. The researchers say the tool preserves the original data values instead of enhancing blurry areas in ways that could alter them.

2026-08-27

Medical Technologies

Dexcom and Abbott Await Medicare Coverage Expansion for Continuous Glucose Monitors

Dexcom and Abbott are awaiting a CMS decision that could expand Medicare coverage for continuous glucose monitoring devices to include patients with type 2 diabetes who do not use insulin. Dexcom expects the decision before the end of 2026, with potential coverage beginning in mid-2027.

2026-08-27

Medical Technologies

Mucosight AI System Analyzes Eye Disease Images in 30 Seconds with NVIDIA Support

A Japanese academic organization has developed the Mucosight AI system to analyze medical images associated with eye diseases and identify suspected cases in about 30 seconds. The model’s development benefited from NVIDIA support and supercomputing resources, with service provision in Japan expected to begin in August 2026.

2026-08-27

Medical Technologies

Legato Startup Unveils AI-Powered Hearing Glasses After Raising $12 Million

Legato has emerged from stealth with $12 million in funding and unveiled Legato Frames, glasses that integrate hearing-assistance technology into the frame arms. The company targets mild to moderate hearing loss, with a launch expected in fall 2026 through select eye-care providers in the United States.

2026-08-26

Medical Technologies

U.S. Court Orders Guardant Health to Pay More Than $245 Million in Patent Dispute

A U.S. court issued a final judgment requiring Guardant Health to pay more than $245.2 million to TwinStrand Biosciences and the University of Washington after finding it had willfully infringed two patents covering DNA sequencing technologies. The judgment also includes 6% royalties on sales of 11 products and a service until the patents expire in March 2033, while the company plans to appeal the decision.

2026-08-26

Medical Technologies

FDA Requests Public Comment on Classifying Certain Medical Device Accessories as Class I Devices

The FDA’s Center for Devices and Radiological Health has issued a proposed list of medical device accessories that may be eligible for independent classification as Class I devices and opened a comment period through October 16, 2026. The action does not mean that the classification has already been approved; rather, it aims to identify accessories for which general controls are sufficient to provide reasonable assurance of safety and effectiveness.

2026-08-25

Medical Technologies

Abbott Receives U.S. Authorization for Sensor That Monitors Glucose and Ketones Together

The U.S. Food and Drug Administration granted Abbott de novo authorization for the Libre Duo 10 Day wearable sensor, which can continuously monitor glucose and ketones in people with diabetes. The company plans to launch it in the United States during 2026, while its price and insurance coverage remain undisclosed.

2026-08-25

Medical Technologies

U.S. Food and Drug Administration Clears New Blood Test from Roche and Eli Lilly to Assess Alzheimer’s

Roche and Eli Lilly’s Elecsys pTau217 test received FDA clearance to help support or rule out the likelihood of Alzheimer’s disease in people aged 55 and older experiencing cognitive decline. Labcorp and Quest Diagnostics plan to launch it nationally, increasing competition in biomarker-based blood tests for the disease.

2026-08-25

Medical Technologies

FDA Selects First Participants in READI-Home Challenge to Develop Devices That Reduce Hospital Readmissions

The U.S. Food and Drug Administration has selected initial participants to advance to the interaction phase of the READI-Home Challenge, which aims to accelerate the development of medical devices for home use after hospital discharge. The current list includes a system for monitoring electrical brain activity and a therapeutic vibrating mattress for infants, while applications continue to be accepted through September 30, 2026.

2026-08-24

Medical Technologies

Turkcell Performs Remote Robotic Surgery via 5G and Network Slicing Technology

Turkcell conducted a remote robotic surgery demonstration between the Turkish ship TCG Anadolu and Kocaeli University, using a 5G network and network slicing technology to isolate data traffic and provide a secure, real-time connection. The company says the demonstration made the ship the first military naval vessel of its kind among Mediterranean countries to have a robotic surgery infrastructure.

2026-08-22

Medical Technologies

Turkey Tests Remote Robotic Surgery Aboard the TCG Anadolu via 5G

Turkey tested, aboard the military vessel TCG Anadolu, a robotic surgery system based on a 5G connection and guidance from physicians at Kocaeli University, as part of a project aimed at developing remote surgery at sea. The current trial was limited to an organ model and recorded a response time of approximately 135 milliseconds.

2026-08-21

Medical Technologies

FDA Authorizes Claria System for Tissue Containment During Laparoscopic Uterine Surgery and Reaffirms Risks of Uncontained Morcellation

The U.S. Food and Drug Administration authorized the Claria System for marketing, a device that combines tissue morcellation and containment during certain laparoscopic uterine surgeries. The agency emphasizes that electromechanical morcellators should be used only in selected patients and with a compatible containment system because of the risk of spreading undetected uterine cancer.

2026-08-20

Medical Technologies

U.S. Food and Drug Administration Authorizes Vitestro’s Robotic Blood-Draw Device

The U.S. Food and Drug Administration has authorized Vitestro’s Aletta, a robotic system that uses imaging, ultrasound, and artificial intelligence to draw blood samples without direct manual intervention by a specialist throughout the procedure. The device may allow one specialist to supervise up to three devices at a time, as the United States faces a shortage of workers trained in blood collection.

2026-08-20